NCT06405451Completed
Respiratory Muscle Training Program in Patients With Multiple Sclerosis
Pilot Experimental Study on the Impact of a Respiratory Muscle Training Program in Patients With Multiple Sclerosis
Source: ClinicalTrials.gov · Last updated 10 Jun 2025
Brief summary (registry, in English)
This is a quasi-experimental pre-post trial aimed at investigating the effects of respiratory muscle training (RMT) as trunk stabilization exercise in patients diagnosed with multiple sclerosis (MS)
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 27 (actual)
- First submitted
- 8 Apr 2024
- Start date
- 9 Apr 2024
- Primary completion date
- 1 Jul 2024
- Lead sponsor
- Universidad Europea de Madrid
- Diseases
- Multiple sclerosis
- NCT number
- NCT06405451
What you commit to
- Study type: Interventional
- Participants enrolled: 27
- From 9 Apr 2024 to the primary completion date, 1 Jul 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Experienced exacerbation or hospitalization within the last 3 months prior to initiating the assessment protocol, nor during the therapeutic intervention process.
- Received a cycle of steroids, intravenously or orally, 6 months prior to the start of the assessment protocol and within the study intervention period.
Other illness
- Diagnosis of another neurological disease or musculoskeletal alteration other than MS.
- Diagnosis of any cardiovascular, respiratory, or metabolic disease, or other conditions that may interfere with this study.
Who the study is looking for
- Confirmed diagnosis of Multiple Sclerosis based on McDonald criteria, with a disease duration of more than two years (relapsing or progressive) (McDonald et al., 2001).
- All multiple sclerosis patients are included according to the Kurtzke Disability Status Scale (EDSS) ANEX II (Kurtzke 1983, Tollár 2020).\*
- Stable medical treatment for at least the six months prior to the intervention (Tollár, 2020).
- Absence of cognitive impairment, with the ability to understand instructions and achieve a score equal to or greater than 24 on the Mini-Mental State Examination (Folstein, Folstein \& McHugh, 1975, Tollár 2020).
Age in the registry: 18 years to 70 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Universidad Europea de Madrid Coordinator of this site? Confirm its status | Villaviciosa de Odón | Spain | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.